Oral janus kinase inhibitors for induction of remission in ulcerative colitis

The primary objective is to evaluate the efficacy and safety of oral JAK inhibitors for induction of remission in patients with active UC.

This is a protocol.

Health topics:

Published:

1 November 2016

Authors:

Anand S, Garg SK, Campbell JP, Singh S, Wadhwa V, Hussein IM, Kumar A, Ahuja V

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Anand S, Garg SK, Campbell JP, Singh S, Wadhwa V, Hussein IM, Kumar A, Ahuja V. Oral janus kinase inhibitors for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No.: CD012420. DOI: 10.1002/14651858.CD012420